Molecule intelOpportunity: StrongEssential

Fluorouracil

18 brands · 10 companies · product forms

ATC: L01BC02 3 DRAP alerts

Opportunity snapshot

Launch attractiveness
50
Market saturation
27
Price room
100
Regulatory risk
80
18
brands
10
companies
Rs 480.57
median price
14
price points
24.2x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 22%

Price room

Across observed sources and strengths
CheapestRs 79.91
MedianRs 480.57
Most expensiveRs 1,934.07
Spread24.2×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 24.20x across 14 trusted points (Rs 79.91-1934.07). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Fluorouracil — each links to its own medicine page.

Regulatory alerts

latest 2023-10-26
Drug Safety Alert: Risk of Seizures with Cephalosporins
Drug Safety Alert: Risk of Kidney Damage with Oral Anticoagulants
Drug Safety Alert:Risk of Potentially Life-threatening Toxicity with Fluorouracil and Cape

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(73) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

10 canonical companies and 18 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 24.20x across 14 trusted points (Rs 79.91-1934.07). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

3 DRAP alert(s), latest 2023-10-26.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.